Axonics, Inc. (AXNX)
NASDAQ: AXNX · IEX Real-Time Price · USD
-0.11 (-0.16%)
May 24, 2024, 4:00 PM EDT - Market closed

Axonics Revenue

Axonics had revenue of $387.14M in the twelve months ending March 31, 2024, with 30.82% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $91.41M with 29.38% year-over-year growth. In the year 2023, Axonics had annual revenue of $366.38M with 33.86% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
3.43B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023366.38M92.68M33.86%
Dec 31, 2022273.70M93.41M51.81%
Dec 31, 2021180.29M68.76M61.64%
Dec 31, 2020111.54M97.72M707.05%
Dec 31, 201913.82M13.11M1,854.74%
Dec 31, 2018707.00K579.00K452.34%
Dec 31, 2017128.00K--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perrigo Company 4.56B
LivaNova 1.19B
HUTCHMED (China) 838.00M
Ultragenyx Pharmaceutical 442.59M
Insmed 315.49M
Axsome Therapeutics 251.02M
PROCEPT BioRobotics 156.33M
Alvotech 114.39M
Revenue Rankings